Related Experiment Video
Updated: Apr 29, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
Interplay between Mdm2 and HIPK2 in the DNA damage response
Xiao-Peng Zhang1, Feng Liu2, Wei Wang3
1National Laboratory of Solid State Microstructures and Department of Physics, Nanjing University, Nanjing 210093, People's Republic of China Kuang Yaming Honors School, Nanjing University, Nanjing 210093, People's Republic of China.
Abstract:
The tumour suppressor p53 is activated to induce cell-cycle arrest or apoptosis in the DNA damage response (DDR). p53 phosphorylation at Ser46 by HIPK2 (homeodomain-interacting protein kinase 2) is a critical event in apoptosis induction. Interestingly, HIPK2 is degraded by Mdm2 (a negative regulator of p53), whereas Mdm2 is downregulated by HIPK2 through several mechanisms. Here, we develop a four-module network model for the p53 pathway to clarify the role of interplay between Mdm2 and HIPK2 in the DDR evoked by ultraviolet radiation. By numerical simulations, we reveal that Mdm2-dependent HIPK2 degradation promotes cell survival after mild DNA damage and that inhibition of HIPK2 degradation is sufficient to trigger apoptosis. In response to severe damage, p53 phosphorylation at Ser46 is promoted by the accumulation of HIPK2 due to downregulation of nuclear Mdm2 in the later phase of the response. Meanwhile, the concentration of p53 switches from moderate to high levels, contributing to apoptosis induction. We show that the presence of three mechanisms for Mdm2 downregulation, i.e. repression of mdm2 expression, inhibition of its nuclear entry and HIPK2-induced degradation, guarantees the apoptosis of irreparably damaged cells. Our results agree well with multiple experimental observations, and testable predictions are also made. This work advances our understanding of the regulation of p53 activity in the DDR and suggests that HIPK2 should be a significant target for cancer therapy.
Insights
The interplay between HIPK2 and Mdm2 regulates the p53 pathway during DNA damage. Mdm2-dependent HIPK2 degradation promotes survival after mild damage, while HIPK2 accumulation triggers apoptosis in severe DNA damage scenarios.
Area of Science:
- Molecular Biology
- Cellular Biology
- Systems Biology
Background:
- The tumor suppressor p53 is crucial for the DNA damage response (DDR), inducing cell-cycle arrest or apoptosis.
- Phosphorylation of p53 at Ser46 by HIPK2 is a key event for apoptosis induction.
- HIPK2 is degraded by Mdm2, a negative regulator of p53, while HIPK2 also downregulates Mdm2.
Purpose of the Study:
- To model the p53 pathway network, focusing on the Mdm2-HIPK2 interplay in the DDR.
- To elucidate the role of this interplay in response to ultraviolet radiation-induced DNA damage.
- To understand how these interactions dictate cell fate decisions (survival vs. apoptosis).
Main Methods:
- Development of a four-module network model for the p53 pathway.
- Numerical simulations to analyze pathway dynamics under varying DNA damage levels.
- Investigating the impact of Mdm2-dependent HIPK2 degradation and its inhibition.
Main Results:
- Mdm2-mediated degradation of HIPK2 promotes cell survival following mild DNA damage.
- Inhibition of HIPK2 degradation is sufficient to induce apoptosis, regardless of damage severity.
- Severe DNA damage leads to HIPK2 accumulation and increased p53 phosphorylation at Ser46, promoting apoptosis.
- Multiple Mdm2 downregulation mechanisms ensure apoptosis in cells with irreparable DNA damage.
Conclusions:
- The dynamic interplay between Mdm2 and HIPK2 is critical for regulating p53 activity in the DDR.
- HIPK2 accumulation, driven by Mdm2 downregulation, is a key switch for apoptosis induction in response to severe DNA damage.
- Targeting HIPK2 presents a promising strategy for cancer therapy by modulating the p53-mediated DDR.
Related Concept Videos
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Abnormal Proliferation
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis
Inhibition of Cdk Activity

